{"title": "Aspirin to fight an expensive global killer infection", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmaceuticals.xml", "value": "Aspirin to fight an expensive global killer infection"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190325101349.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190325101349.htm", "summary": "Tuberculosis is far from eradicated around the world and still infects more than 1,400 people per year in Australia. Antibiotic resistant tuberculosis is particularly deadly and expensive to treat, costing up to $250,000 to treat a single case in Australia. Scientists have been working on new ways to treat tuberculosis by increasing the effectiveness of the immune system.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmaceuticals.xml", "value": "Tuberculosis is far from eradicated around the world and still infects more than 1,400 people per year in Australia. Antibiotic resistant tuberculosis is particularly deadly and expensive to treat, costing up to $250,000 to treat a single case in Australia. Scientists have been working on new ways to treat tuberculosis by increasing the effectiveness of the immune system."}, "published": "Mon, 25 Mar 2019 10:13:49 EDT", "published_parsed": [2019, 3, 25, 14, 13, 49, 0, 84, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190325101349.htm", "guidislink": false}